The company
Invivyd, Inc.
IVVD · Nasdaq
IVVD stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 32 weeks. It is 39.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 32
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $125K
- Insider sales, 12 months
- $1.1M
- Officials’ trades on record
- 0
- Institutions holding
- 124 (-9)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Robert D. Allen IIIChief Scientific Officer | sold | 17,043at $0.8429 | 18 Aug 2026filed 18 Aug 2026 |
| Jill AndersenChief Legal Officer, Secretary | sold | 30,706at $0.8429 | 18 Aug 2026filed 18 Aug 2026 |
| William E. DukeChief Financial Officer | sold | 18,425at $0.8429 | 18 Aug 2026filed 18 Aug 2026 |
| Julie GreenChief Human Resources Officer | sold | 18,425at $0.8429 | 18 Aug 2026filed 18 Aug 2026 |
| Timothy Edward LeeChief Commercial Officer | sold | 18,425at $0.8429 | 18 Aug 2026filed 18 Aug 2026 |
| Robert D. Allen IIIChief Scientific Officer | sold | 20,679at $0.722 | 17 Aug 2026filed 18 Aug 2026 |
| Jill AndersenChief Legal Officer, Secretary | sold | 37,256at $0.722 | 17 Aug 2026filed 18 Aug 2026 |
| William E. DukeChief Financial Officer | sold | 22,355at $0.722 | 17 Aug 2026filed 18 Aug 2026 |
| Julie GreenChief Human Resources Officer | sold | 22,355at $0.722 | 17 Aug 2026filed 18 Aug 2026 |
| Timothy Edward LeeChief Commercial Officer | sold | 22,355at $0.722 | 17 Aug 2026filed 18 Aug 2026 |
| Jill AndersenChief Legal Officer, Secretary | sold | 34,939at $1.58 | 18 Feb 2026filed 18 Feb 2026 |
| Timothy Edward LeeChief Commercial Officer | sold | 20,964at $1.58 | 18 Feb 2026filed 18 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 34,173,104$30.0M | +34,173,104 |
| BVF INCadded · filed 14 Aug 2026 | 28,165,000$24.6M | +8,640,000+44.3% |
| MAVERICK CAPITAL LTDunchanged · filed 14 Aug 2026 | 18,970,913$16.6M | 00.0% |
| PERCEPTIVE ADVISORS LLCreduced · filed 14 Aug 2026 | 18,490,636$16.1M | -2,368,667−11.4% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 16,134,885$14.1M | +11,853,095+276.8% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 10,496,507$9.2M | +422,181+4.2% |
| M28 Capital Management LPunchanged · filed 13 Aug 2026 | 9,248,250$8.1M | 00.0% |
| Saturn V Capital Management LPreduced · filed 14 Aug 2026 | 8,392,288$7.3M | -2,556,796−23.4% |
| Soleus Capital Management, L.P.unchanged · filed 11 Aug 2026 | 7,708,727$6.7M | 00.0% |
| Point72 Asset Management, L.P.added · filed 14 Aug 2026 | 7,542,061$6.6M | +7,498,130+17068.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.